[1] Oboki K, Ohno T, Saito H, et al. Th17 and allergy.Allergol Int. 2008 ,57(2):121-134. [2]Liu W, Putnam AL, Xu-Yu Z, et a1. CDl27 expression inversely correlates with FoxP3 and suppressive function of human CD4+Treg cells. J Exp Med,2006,203(7):1701-1711. [3]王 盈,周磊明,宫菊丽等.中国健康人外周血中具有CD4+CD25+CDl27-特征的调节性T 细胞频率.细胞与分子免疫学杂志,2007,23(9):816-818. [4] Gri G, Piconese S, Frossi B, et al. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity. 2008,29(5):771-781. [5] Akdis CA, Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells.J Allergy Clin Immunol. 2009 ,123(4):735-746. [6] Yang XF. Factors regulating apoptosis and homeostasis of CD4+ CD25(high) FOXP3+ regulatory T cells are new therapeutic targets.Front Biosci. 2008 , 13:1472-1499. [7]Tesmer LA, Lundy SK, Sarkar S, et al. Th17 cells in human disease. Immunol Rev. 2008,823(1):87-113. [8] 伍斌,谢红付,张江林,等.苦参素治疗慢性荨麻疹患者疗效及外周血Foxp3调节性T细胞的检测.中华皮肤科杂志,2009,42(9):635-637. [9] Dos Santos JC, Azor MH, Nojima VY, et al. Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria. Int Immunopharmacol. 2008,8(10):1433-1440. [10] Chen WC, Chiang BL, Liu HE, et al. Defective functions of circulating CD4+CD25+ and CD4+CD25- T cells in patients with chronic ordinary urticaria.J Dermatol Sci, 2008 ,51(2):121-130. |